Evaluate Audiological Outcome of Cochlear Implant Program in Sohag University Hospital
Assessment of Audiological Outcome of Cochlear Implant Program at Sohag University Hospital
Evaluation of the outcome of cochlear implantation (CI) is very important issue since adequate hearing is linked to improved communication outcomes and school performance, development of speech and language, enhances speech perception in quiet and noise and even allows CI recipients to use the telephone.
As well as there is a growing need for a widely used set of international quality standards on minimal outcome measurements to determine outcomes in CI recipients, monitor the auditory progress of CI recipients over time and to be able to relate on important issues as the most ideal age for implantation and the cut-off audiological thresholds for CI indication.
This study will be conducted to evaluate outcome of cochlear implantation in sohag university hospital.
Aim of work:
To evaluate the outcome of cochlear implantation in Sohag university hospital.
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Materials and Methods:
- It is a prospective study on cochlear implant recipients in sohag cochlear implant unite from 2014: 2020.
• Subjects: Cochlear implant recipients in sohag cochlear implant unite from 2014: 2020.
Subjects will be divided into 2 categories:
Prelingual patients: subdivided into 3 groups
- Cochlear implant recipient with no medical or radiological issues.
- Cochlear implant recipients with medical concern or with other disabilities as syndromic patients.
- Cochlear implant recipients with radiological issues.
Postlingual patients: subdivided into 3 groups
- Cochlear implant recipients with no medical or radiological issues.
- Cochlear implant recipients with medical concern or with other disabilities as syndromic patients.
- Cochlear implant recipients with radiological issues.
Inclusion criteria:
Patients who received cochlear implant at Sohag university hospital and fulfill the following criteria:
- Age: from one year up to 60.
- Prelingual who had one year of regular speech therapy
Postlingual patients.
• Method:
Background information:
- History: Age, gender, Age at which hearing loss occur, cause of hearing loss, duration of hearing loss.
- Family support.
- Expectation of patient (if post lingual patient).
- Expectation of parents.
- Hearing assessment:
- Aided Pure Tone Audiometry (PTA) level.
Speech perception
- speech perception threshold (SRT).
- Speech perception in quiet for patients who developed language and postlingual patients using phonetically Balanced words for kinder garden ( PBKG) words, phonetically balanced words for adult (PBA), word intelligibility by picture identification (WIPI) or minimal birds.
Speech in noise test: for patients who developed language and post lingual patients.
3- Impedance telemetry. 4- Electrically evoked action potential (ECAP). 5- Cortical evoked P1N1 potential. Informed written consent will be taken from all Participant patients or their legal guardians.
This search will submit for approval from Research Ethics committee of Sohag Faculty of medicine.
All investigation will be done cost free.
Studietype
Inschrijving (Verwacht)
Contacten en locaties
Studiecontact
- Naam: Shahenda A Moussa, Master
- Telefoonnummer: 2001014489937
- E-mail: shahenda.abdelmaten@med.sohag.edu.eg
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
-
Patients who received cochlear implant at Sohag university hospital and fulfill the following criteria:
- Age: from one year up to 60.
- Prelingual who had one year of regular speech therapy
- Postlingual patients.
Exclusion Criteria:
- none
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
pre lingual
aided response, speech perception threshold impedance telemetry electrically evoked action potential p1n1 cortical evoked potential
|
aided response, speech, evoked potential
Andere namen:
|
|
post lingual
aided response, speech perception threshold speech in noise impedance telemetry electrically evoked action potential p1n1 cortical evoked potential
|
aided response, speech, evoked potential
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Hearing threshold for Cochlear implant users at Sohag University Hospital
Tijdsspanne: one year postoperative
|
Pure Tone Audiometery will be used to measure the hearing threshold in decible at each frequnecy from 250 Hz to 8000 Hz
|
one year postoperative
|
|
Central processing of speech for cochlear implant users at Sohag university Hospital
Tijdsspanne: one year postoperative
|
Auditory Evoked Potential for detection of P1 wave which generated at central auditory area, Presence of P1 wave means normal speech processing, while absence of P1 wave means abnormal speech processing
|
one year postoperative
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Shahenda A Moussa, Master, Sohag University, Faculty of Medicine
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Verwacht)
Primaire voltooiing (Verwacht)
Studie voltooiing (Verwacht)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- Soh-Med-21-01-06
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .